Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Infection
|
September 1, 1996
Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence
J Treib, A Haass, S T Kiessig, et al.
Neurology
|
March 10, 2004
Clinical and neuroimaging features of "idiopathic" syringomyelia
E I Bogdanov, J D Heiss, E G Mendelevich, et al.
Transfusion Medicine Reviews
|
April 2, 2019
Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module
Kathryn A Haass, Mathew R P Sapiano, Alexandra Savinkina, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5
H Kroemer, A Haass, K Müller, et al.
Arzneimittel-Forschung
|
January 1, 1997
Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch
J Treib, A Haass, G Pindur, et al.
Der Radiologe
|
April 24, 2009
[Carotid artery stenting for acute stroke]
P Papanagiotou, C Roth, I Q Grunwald, et al.
Arzneimittel-Forschung
|
November 1, 1996
Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases
J Treib, A Haass, G Pindur, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 31, 1986
[Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks]
A Haass, H Kroemer, H Jäger, et al.
Haemostasis
|
August 5, 1998
No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starch
M Stoll, J Treib, J F Schenk, et al.
Der Radiologe
|
September 30, 2006
[Stroke]
F J Ahlhelm, N Naumann, A Haass, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Infection
|
September 1, 1996
Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence
J Treib, A Haass, S T Kiessig, et al.
Neurology
|
March 10, 2004
Clinical and neuroimaging features of "idiopathic" syringomyelia
E I Bogdanov, J D Heiss, E G Mendelevich, et al.
Transfusion Medicine Reviews
|
April 2, 2019
Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module
Kathryn A Haass, Mathew R P Sapiano, Alexandra Savinkina, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5
H Kroemer, A Haass, K Müller, et al.
Arzneimittel-Forschung
|
January 1, 1997
Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch
J Treib, A Haass, G Pindur, et al.
Der Radiologe
|
April 24, 2009
[Carotid artery stenting for acute stroke]
P Papanagiotou, C Roth, I Q Grunwald, et al.
Arzneimittel-Forschung
|
November 1, 1996
Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases
J Treib, A Haass, G Pindur, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 31, 1986
[Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks]
A Haass, H Kroemer, H Jäger, et al.
Haemostasis
|
August 5, 1998
No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starch
M Stoll, J Treib, J F Schenk, et al.
Der Radiologe
|
September 30, 2006
[Stroke]
F J Ahlhelm, N Naumann, A Haass, et al.
Page
of 11